GSK turnover falls in Q3
Pharmaceutical turnover down 3% to £5,553m and Consumer Healthcare sales up 4% to £1,260m. Excluding pandemic products, group sales were level in the quarter. Excluding pandemic products and
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Piperacillin and tazobactam for injection is an antibacterial treatment indicated for use in adults with certain types of moderate to severe infections caused by piperacillin-resistant, piperacillin/tazobactam susceptible, ß-lactamase